RTI Surgical, a CDMO in regenerative medicine, has entered into an agreement to acquire Collagen Solutions, a global supplier of engineered medical-grade collagen and xenograft tissue with applications in cardiac, sports medicine and orthopedics.   The acquisition expands RTI’s portfolio of allograft and xenograft biomaterials at scale and follows the company’s acquisition of Cook Biotech earlier in the year. RTI’s product portfolio enables the company to partner with customers and surgeons to...